Genetic and Molecular Dissection of Wnt Pathway Activation
Wnt 通路激活的遗传和分子剖析
基本信息
- 批准号:10417184
- 负责人:
- 金额:$ 62.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdenosine Diphosphate RiboseAnimalsBehaviorBiochemicalBiologicalBiological AssayCell Differentiation processCell ProliferationCellsCollaborationsColorectal CancerComplementComplexDevelopmentDifferentiation and GrowthDiseaseDissectionDrosophila genusGene ActivationGeneticGenetic TranscriptionGoalsHomeostasisKnowledgeLaboratoriesMaintenanceMalignant NeoplasmsMass Spectrum AnalysisMembraneModelingMolecularMonitorNatural regenerationNuclearPathway AnalysisPathway interactionsPhosphotransferasesPolymerasePost-Translational Protein ProcessingReceptor ActivationResearchResearch PersonnelRoleScaffolding ProteinSignal TransductionSignal Transduction PathwayTankyraseTissuesTumor Suppressor ProteinsWNT Signaling PathwayWorkbeta catenincell growthcombatdesigndevelopmental diseasegenome wide screenhuman diseasein vivoin vivo Modelinnovationnovel therapeutic interventionprogramsreceptorreconstitutiontherapeutic targetubiquitin ligase
项目摘要
PROJECT SUMMARY
The evolutionarily-conserved Wnt signal transduction pathway directs cell proliferation and differentiation
during animal development and tissue homeostasis. Despite the fact that deregulation of Wnt signaling
underlies numerous developmental disorders and cancers, including nearly all colorectal cancers, many of
these mechanisms remain poorly understood. Thus, a deeper understanding of the mechanisms that activate
this pathway will guide the development of new therapeutic strategies to combat Wnt-driven diseases. The
long-term goal of the PI’s research program is to elucidate the mechanisms that activate Wnt signaling during
animal development and to use this knowledge to identify control points in the pathway susceptible to
therapeutic targeting in Wnt-driven diseases. In support of this effort, the PI and her laboratory group have
established innovative in vivo models in Drosophila that have revealed unanticipated functions of three core
Wnt pathway effectors: the tumor suppressor, APC; the scaffold protein, Axin; and the ADP-ribose polymerase,
Tankyrase. Building on these findings and enabled by genome-wide screens designed to uncover new Wnt
signaling regulators, the current project will address three major unsolved questions: 1) how the membrane-
associated receptor activation complex is assembled and activated; 2) how the negative regulatory cytosolic
beta-catenin destruction complex is inhibited upon Wnt stimulation; and 3) how the nuclear beta-catenin-TCF
transcription complex is activated. To elucidate the role of previously unknown Wnt pathway activators, this
project will couple genetic, cell biological and biochemical approaches with in vivo assays previously
developed by the PI to monitor pathway activation within Wnt signaling gradients. It will apply an innovative
focus centered on three components: a deubiquitinating complex essential for Wnt receptor stability, a ubiquitin
ligase essential for signaling activation, and a kinase that activates the beta-catenin-TCF transcription
complex. This work is complemented by productive collaborations with investigators who have expertise in the
biochemical reconstitution of Wnt signaling, Wnt pathway analysis in vertebrate models, and in the
identification of Wnt-dependent post-translational protein modifications using mass spectrometry analysis. The
successful completion of this work will provide an understanding of: 1) the control of Wnt receptor activity; 2)
the control of the beta-catenin destruction complex; 3) the activation of the Wnt transcription complex; and 4)
novel therapeutic strategies to target Wnt-driven diseases.
项目摘要
进化保存的Wnt信号转导途径指导细胞增殖和分化
在动物发育和组织稳态期间。尽管Wnt信号的放松管制
基础众多发育障碍和癌症,包括几乎所有有色癌症,许多
这些机制仍然知之甚少。这是对激活机制的更深入的理解
该途径将指导开发新的治疗策略,以打击WNT驱动的疾病。这
PI研究计划的长期目标是阐明激活Wnt信号传导的机制
动物发展并利用这些知识来识别容易受到影响的路径中的控制点
WNT驱动疾病中的治疗靶向。为了支持这项努力,PI和她的实验室小组有
果蝇中建立的创新体内模型,这些模型揭示了三个核心的意外功能
Wnt途径效应:肿瘤抑制剂,APC;支架蛋白Axin;和ADP-核糖聚合酶,
坦克酶。以这些发现为基础,并由全基因组屏幕启用,旨在发现新的Wnt
信号调节器,当前项目将解决三个主要未解决的问题:1)膜如何
相关的接收器激活复合物被组装并激活; 2)负调控性胞质如何
Wnt刺激抑制了β-catenin的破坏复合物; 3)核β-catenin-TCF如何
转录复合物被激活。为了阐明先前未知的Wnt途径激活剂的作用,
项目将将遗传性,细胞生物学和生化方法与之前的体内分析相结合
由PI开发以监视Wnt信号传导梯度内的途径激活。它将应用创新
重点集中于三个组成部分:泛素化复合物对于Wnt接收器稳定性至关重要,泛素
连接酶对于信号激活必不可少的,以及激活β-catenin-TCF转录的激酶
复杂的。这项工作是由与具有专业知识的调查人员合作完成的
Wnt信号传导的生化重构,脊椎动物模型中的WNT途径分析以及
使用质谱分析鉴定WNT依赖性后翻译后蛋白质修饰。这
这项工作的成功完成将提供:1)Wnt受体活动的控制; 2)
β-catenin破坏复合物的控制; 3)Wnt转录复合物的激活;和4)
针对WNT驱动疾病的新型治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yasmath Ahmed其他文献
Yasmath Ahmed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yasmath Ahmed', 18)}}的其他基金
A Cereblon signaling network in Wnt-driven cancers
Wnt 驱动的癌症中的 Cereblon 信号网络
- 批准号:
10670555 - 财政年份:2023
- 资助金额:
$ 62.98万 - 项目类别:
Super-resolution spinning disk confocal microscope for Dartmouth Life Sciences
用于达特茅斯生命科学的超分辨率转盘共焦显微镜
- 批准号:
10427997 - 财政年份:2022
- 资助金额:
$ 62.98万 - 项目类别:
Genetic and Molecular Dissection of Wnt Pathway Activation
Wnt 通路激活的遗传和分子剖析
- 批准号:
10163216 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10063347 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10217057 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10653134 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10424450 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Role of ADP-ribosylation in Wnt Pathway Activation
ADP-核糖基化在 Wnt 通路激活中的作用
- 批准号:
9892659 - 财政年份:2017
- 资助金额:
$ 62.98万 - 项目类别:
Role of ADP-ribosylation in Wnt Pathway Activation
ADP-核糖基化在 Wnt 通路激活中的作用
- 批准号:
9383497 - 财政年份:2017
- 资助金额:
$ 62.98万 - 项目类别:
APC Tumor Suppressor in Cell Differentiation and Death
APC 肿瘤抑制因子在细胞分化和死亡中的作用
- 批准号:
9383490 - 财政年份:2017
- 资助金额:
$ 62.98万 - 项目类别:
相似国自然基金
靶向聚腺苷二磷酸核糖聚合酶-1(PARP-1)的99mTc和68Ga标记肿瘤分子探针的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
靶向聚腺苷二磷酸核糖聚合酶-1(PARP-1)的99mTc和68Ga标记肿瘤分子探针的研究
- 批准号:22276015
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
多聚二磷酸腺苷核糖探针的合成及生物活性研究
- 批准号:22207114
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
锌指蛋白SZF1及单腺苷二磷酸核糖化修饰调控植物蛋白翻译与免疫反应的机理
- 批准号:32170555
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
腺苷二磷酸核糖ADPR双位点激活TRPM2通道的动态门控过程研究
- 批准号:32071102
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:
10641934 - 财政年份:2022
- 资助金额:
$ 62.98万 - 项目类别:
Inhibiting Viral Macrodomains Using Structure-Based Design
使用基于结构的设计抑制病毒宏域
- 批准号:
10512631 - 财政年份:2022
- 资助金额:
$ 62.98万 - 项目类别:
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:
10540084 - 财政年份:2022
- 资助金额:
$ 62.98万 - 项目类别:
Genetic and Molecular Dissection of Wnt Pathway Activation
Wnt 通路激活的遗传和分子剖析
- 批准号:
10163216 - 财政年份:2020
- 资助金额:
$ 62.98万 - 项目类别:
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus Infection
研究 ADP-核糖基化如何影响冠状病毒感染期间的先天免疫
- 批准号:
9428897 - 财政年份:2018
- 资助金额:
$ 62.98万 - 项目类别: